\n<\/p>\n
New Efforts to Combat Childhood Brain Cancer<\/strong><\/p>\n According to St. Jude’s Children\u2019s Hospital, around 400,000 children around the world are expected to be diagnosed with cancer this year. In the U.S., advances in research and treatment have significantly improved survival rates, with 80% of kids living at least five years after diagnosis. However, there\u2019s still a long way to go, especially in finding cures for rarer types of cancer.<\/p>\n Fernando Goldsztein knows this struggle all too well. His son, Frederico, was diagnosed with medulloblastoma, the most common type of brain tumor in children, when he was just nine years old. While medulloblastoma is rare\u2014affecting only five out of one million kids each year\u2014it remains difficult to fund research for new treatments.<\/p>\n “When I was told there was nothing more we could do, my world fell apart,” Fernando recounted. “Doctors advised me to go home and spend time with my son.”<\/p>\n Frederico experienced a relapse, prompting Fernando to take action. \u201cAfter two weeks of processing the news, I realized I had to do something,\u201d he said.<\/p>\n Frederico continues to battle recurrent medulloblastoma today at age 18. To accelerate research, Fernando founded the Medulloblastoma Initiative (MBI) in partnership with Dr. Roger Packer, a prominent researcher in the field.<\/p>\n \u201cWe aim to find a cure as quickly as possible,\u201d Fernando explained. \u201cCollaboration is key, and our scientists work closely together as a team.\u201d<\/p>\n The MBI has united over a dozen research labs globally, enabling rapid progress on important studies. \u201cEach lab contributes a vital piece, allowing us to make significant advancements quickly,\u201d he said.<\/p>\n Since the last update from MBI, they have helped fast-track at least two clinical trials for medulloblastoma and more research is underway. \u201cWe are excited about the promising results we\u2019re seeing,\u201d Fernando added.<\/p>\n In one funded clinical trial, researchers are programming patients’ white blood cells to target and destroy cancer cells, showing encouraging results in early tests. Additionally, scientists at the University of Florida are testing a possible mRNA-based cancer vaccine that may enhance the immune response against tumors.<\/p>\n Fernando emphasizes that all donations to the MBI directly support research and trials aimed at helping kids like Frederico. \u201cHe\u2019s doing well now, but we know these tumors can return. That\u2019s why we\u2019re moving fast to help him and many other young patients,\u201d he stated.<\/p>\n For more information and to support the Medulloblastoma Initiative, interested individuals can find resources and donation options online.<\/p>\n\n","protected":false},"excerpt":{"rendered":" New Efforts to Combat Childhood Brain Cancer According to St. Jude’s Children\u2019s Hospital, around 400,000 children around the world are expected to be diagnosed with cancer this year. In the U.S., advances in research and treatment have significantly improved survival rates, with 80% of kids living at least five years after diagnosis. However, there\u2019s still<\/p>\n","protected":false},"author":1,"featured_media":17022,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"categories":[29],"tags":[5378,18866,717,20851],"class_list":["post-17021","post","type-post","status-publish","format-standard","has-post-thumbnail","category-world-news","tag-cancer","tag-cancer-research","tag-science","tag-special-report"],"_links":{"self":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts\/17021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/comments?post=17021"}],"version-history":[{"count":0,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts\/17021\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/media\/17022"}],"wp:attachment":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/media?parent=17021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/categories?post=17021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/tags?post=17021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}